- Home
- LNZA vs MLSS Comparison
LNZA vs MLSS Comparison
Compare LNZA & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNZA
- MLSS
- Stock Information
- Founded
- LNZA 2005
- MLSS 1989
- Country
- LNZA United States
- MLSS United States
- Employees
- LNZA N/A
- MLSS N/A
- Industry
- LNZA Major Chemicals
- MLSS Industrial Specialties
- Sector
- LNZA Industrials
- MLSS Health Care
- Exchange
- LNZA Nasdaq
- MLSS Nasdaq
- Market Cap
- LNZA 65.7M
- MLSS 74.9M
- IPO Year
- LNZA N/A
- MLSS 1995
- Fundamental
- Price
- LNZA $0.28
- MLSS $0.67
- Analyst Decision
- LNZA Hold
- MLSS Buy
- Analyst Count
- LNZA 2
- MLSS 1
- Target Price
- LNZA $2.00
- MLSS $1.25
- AVG Volume (30 Days)
- LNZA 2.3M
- MLSS 107.6K
- Earning Date
- LNZA 08-07-2025
- MLSS 08-13-2025
- Dividend Yield
- LNZA N/A
- MLSS N/A
- EPS Growth
- LNZA N/A
- MLSS N/A
- EPS
- LNZA N/A
- MLSS N/A
- Revenue
- LNZA $48,831,000.00
- MLSS $8,613,503.00
- Revenue This Year
- LNZA $58.17
- MLSS $29.14
- Revenue Next Year
- LNZA $10.92
- MLSS $20.19
- P/E Ratio
- LNZA N/A
- MLSS N/A
- Revenue Growth
- LNZA N/A
- MLSS N/A
- 52 Week Low
- LNZA $0.14
- MLSS $0.57
- 52 Week High
- LNZA $2.74
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- LNZA 50.36
- MLSS 28.44
- Support Level
- LNZA $0.25
- MLSS $0.61
- Resistance Level
- LNZA $0.33
- MLSS $0.81
- Average True Range (ATR)
- LNZA 0.04
- MLSS 0.06
- MACD
- LNZA -0.00
- MLSS -0.02
- Stochastic Oscillator
- LNZA 37.63
- MLSS 28.57
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.